Skip to main content
OpenTrials
Completed

NCT Number: NCT01903148

Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations

The purpose of this study is to evaluate the impact of the last recommendations of the European Anemia Working Group ERBP in the anemia management in the achievement of the therapeutic goal of Hb 11-12 g/dL.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anemia Hematologic Diseases Hemic and Lymphatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Puerto Real, Cadiz, Andalusia, Spain

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults patients with anemia secondary to chronic kidney disease (CKD) not on dialysis.
  • Patients starting anemia treatment (naïve) after six months of the last recommendations of the European Anemia Working Group ERBP (January 2011).
  • Patients in treatment who changed from previous ESA treatment since January 2011 (converted patients

Exclusion criteria

  • Patients in Erythropoiesis Stimulating Agents (ESA) dose adjustment period.
  • Kidney transplant patients.

Treatment and study plan

Primary outcomes

  1. % Patients Achieving Target Hemoglobin Levels

    Time frame: 1 day because is a crosssectional study with only a visit

    % patients with Hb levels between 11-12 mg/dl

Secondary outcomes

  1. Hemoglobin Levels Per Type of Patients

    Time frame: 1 day

    levels Hb and type of patients

  2. Patients With Hb>12

    Time frame: 1 day

  3. % Patients With Erythropoiesis Stimulating Agents (ESA) Therapy

    Time frame: 1 day

    know the treatments ESA for maintenance of hb levels

  4. Iron Treatment

    Time frame: 1 day

    Patients with supplementary Iron treatment to ESA

  5. Patients With Hb<11

    Time frame: 1 day

Sponsors and collaborators

Lead sponsor

Fundación Senefro

Other

Registry information

Official study title

ANEMIA MANAGEMENT IN CHRONIC KIDNEY DISEASE NOT ON DIALYSIS PATIENTS AFTER THE ERBP WORKING GROUP RECOMMENDATIONS

Acronym: ACERCA

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Jul 19, 2013
Registry last updated
Jan 1, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.